Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD3 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | PELI2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | IRGQ | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | MAPK8 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | ZNF230 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | TMEM201 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | KLHL25 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | CCT4 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | CDH24 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | ZNF891 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |